findmyKOL
Clinical trialNCT03770468CompletedObservational

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

SponsorEuropean Organisation for Research and Treatment of Cancer - EORTCEnrollment599Glioblastoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Universitaetsklinikum Wien - Akh Uniklinieken

    Vienna, Austria

Belgium
  • Hopitaux Universitaires Bordet-Erasme

    Brussels, Belgium

France
  • Chu Lyon - Hopital Neurologique Pierre Wertheimer

    Bron, France

  • Chru de Lille

    Lille, France

  • Hopitaux de Marseille - Hôpital de la Timone (aphm)

    Marseille, France

  • Institut Du Cancer de Montpellier

    Montpellier, France

  • Chu de Nice - Hopital Pasteur

    Nice, France

  • Hopitaux de Paris - Hopital Saint-Louis

    Paris, France

  • Hopitaux de Paris - la Pitie Salpetriere

    Paris, France

  • Chu D'Amiens - Chu Amiens - Hopital Sud

    Salouël, France

Germany
  • Universitaetsklinikum Bonn

    Bonn, Germany

  • Universitaetsklinikum Carl Gustav Carus

    Dresden, Germany

  • Universitaetsklinikum - Essen

    Essen, Germany

  • Ronellenfitsch Michael

    Frankfurt, Germany

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Universitaetsklinikum Heidelberg

    Heidelberg, Germany

  • Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern

    München, Germany

  • Technische Universitaet Muenchen - Klinikum Rechts Der Isar

    München, Germany

  • Universitaetsklinikum Regensburg

    Regensburg, Germany

Greece
  • Hygeia Hospital

    Athens, Greece

Italy
  • Azienda Ospedaliera Di Padova - Istituto Oncologico Veneto Irccs

    Padova, Italy

  • Azienda Ospedaliera Città Della Salute E Della Scienza Di Torino - Ospedale San Giovanni

    Torino, Italy

Netherlands
  • Amsterdam Umc - Locatie Vumc

    Amsterdam, Netherlands

  • Erasmus Mc

    Rotterdam, Netherlands

Switzerland
  • Centre Hospitalier Universitaire Vaudois - Lausanne

    Lausanne, Switzerland

  • Univ. Spital Zurich

    Zurich, Switzerland

United States
  • Dana-Farber Cancer Institute & Harvard Medical School

    Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jul 2015
Primary completion
18 Aug 2023
Completion
18 Aug 2023
Last update posted
8 Mar 2024
Registered enrollment
599
Registry id
NCT03770468
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.